Prazosin (International)
In the US, Prazosin (prazosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Anxiety and Stress, Benign Prostatic Hyperplasia, Heart Failure, High Blood Pressure, Nightmares, Post Traumatic Stress Disorder and Raynaud's Syndrome.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C02CA01
CAS registry number (Chemical Abstracts Service)
0019216-56-9
Chemical Formula
C19-H21-N5-O4
Molecular Weight
383
Therapeutic Categories
Antihypertensive agent
Peripheral vasodilator
Treatment of heart failure
α₁-adrenoceptor antagonist (α₁-blocker)
Treatment of symptoms of benign prostatic hyperplasia
Chemical Name
Piperazine, 1-(4-amino-6,7-dimetoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-
Foreign Names
- Prazosinum (Latin)
- Prazosin (German)
- Prazosine (French)
- Prazosina (Spanish)
Generic Names
- Prazosin (OS: DCIT, BAN)
- Prazosine (OS: DCF)
- Furazosin (IS)
- Prazosin Hydrochloride (OS: BANM, USAN, JAN)
- CP 12299-1 (Pfizer) (IS)
- Furazosin hydrochloride (IS)
- Prazosin Hydrochloride (PH: BP 2018, JP XVII, USP 41)
- Prazosin hydrochloride (PH: Ph. Eur. 9)
- Prazosine (chlorhydrate de) (PH: Ph. Eur. 9)
- Prazosinhydrochlorid (PH: Ph. Eur. 9)
- Prazosini hydrochloridum (PH: Ph. Eur. 9)
Brand Names
- Alpress LP
Pfizer, Tunisia - CP-Prazo
Christo, Hong Kong - Damin
Shou Chan, Taiwan - Hyprosin
Pacific, Taiwan - Minipres
Pfizer, Ecuador; Pfizer, Spain - Minipress
Pfizer, Egypt; Pfizer U.S., United States - Minipress 2 mg
Pfizer, Hungary - Praten
Labinco, Colombia - Pratsiol
Orion, Taiwan - Prazocin
Johnlee, India - Alphapress
Renata, Bangladesh - Alpress LP 2,5 mg
Pfizer, France - Alpress LP 5 mg
Pfizer, France - Apo-Prazo
Apotex, Canada; Apotex, Hong Kong; Apotex, Singapore - Apo-Prazosin
Apotex, Australia; Apotex, New Zealand - Atodel
Pharmaland, Thailand; Remedica, Cyprus - Chemmart Prazosin
Apotex, Australia - Ensibest
Best, Mexico - Hypovase
Pfizer, United Kingdom; Pfizer, Ireland - Lopress
Siam Bheasach, Thailand - Minipres
Pfizer, Mexico - Minipress
Laphal, France; Pfizer, Australia; Pfizer, Belgium; Pfizer, Hong Kong; Pfizer, Kuwait; Pfizer, Malaysia; Pfizer, Pakistan; Pfizer, Singapore; Pfizer, Taiwan; Pfizer Japan, Japan - Minipress 1 mg retard
Pfizer, Hungary - Minipress 1mg
Pfizer, Luxembourg - Minipress 2 mg retard
Pfizer, Hungary - Minipress 2mg
Pfizer, Luxembourg - Minipress 4 mg retard
Pfizer, Hungary - Minipress 5mg
Pfizer, Luxembourg - Minipress 6 mg retard
Pfizer, Hungary - Minipress SR
Wyeth Pharma, Brazil - Minipress-XL
Pfizer, India - Minpres
Pfizer, Venezuela - Polpressin
Polpharma, Lithuania - Polypress
Central Poly, Thailand - Pratsiol
Orion Pharma, Finland; Pharmacare, South Africa - Prazopress
Sun, India - Prazosin Double-Crane Pharm
CR Double-Crane, China - Prazosin Hydrochloride
Ivax, United States; Mylan, United States; Teva, United States - Prazosin Sopharma
Sopharma, Bulgaria - Prazosin T.O.
T.O. Chemicals, Thailand - Prazosina
Data Pharm., Colombia - Sanosin
Sanjivani, India - Terry White Chemists Prazosin
Apotex, Australia - Teva-Prazosin
Teva Canada, Canada - Vasoflex
Alkaloid, Bosnia & Herzegowina; Alkaloid, Macedonia
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.